scholarly journals Medical oncology group of Australia: taking a leading role in medical oncology education, patient care & research

2018 ◽  
Vol 29 ◽  
pp. vii5
Author(s):  
Christos S. Karapetis
1963 ◽  
Vol 53 (6) ◽  
pp. 965-969 ◽  
Author(s):  
Ruth Freeman ◽  
Cecil G. Sheps ◽  
Helen G. Tibbitts ◽  
Glenn G. Lamson

2021 ◽  
Vol 11 (33) ◽  
pp. 157-168
Author(s):  
Larissa Grispan e Silva Guimarães ◽  
Natália Shinkai Binotto ◽  
Stela Faccioli Ederli ◽  
Mauren Teresa Grubisich Mendes Tacla

Apresentar o processo de elaboração de um pacote de medidas para manejo da dor de crianças submetidas à punção venosa pela equipe de enfermagem. Pesquisa Convergente Assistencial, do tipo antes e após intervenção, realizada com a equipe de enfermagem de uma unidade pediátrica do sul do Brasil. Elaboração de pacote de medidas com seis estratégias selecionadas pela equipe de enfermagem a serem utilizadas antes e durante a punção venosa: preparo da criança e/ou acompanhante, posicionamento da criança, distração, amamentação, solução adocicada associada ou não à sucção não nutritiva e anestésico tópico. Os participantes manifestaram satisfação quanto ao modo de elaboração do mesmo, destacando a contribuição deste para seu crescimento profissional. O pacote de medidas otimizou a adoção das estratégias para manejo da dor. A Pesquisa Convergente Assistencial alicerçada na prática baseada em evidências mostrou-se adequada, visto que propiciou a aplicação de achados científicos no cenário assistencial considerando suas particularidades.Descritores: Manejo da Dor, Criança, Cateterismo Periférico, Enfermagem Baseada em Evidências. Management of pediatric venipuncture pain: a package of measuresAbstract: To present the process of elaboration of a patient care package for pain management in children undergoing venipuncture by the nursing staff. Convergent Care Research, before and after intervention, conducted with the nursing staff of a southern pediatric unit in Brazil. Patient care packege with six strategies, selected by the nursing staff, to be used before and during venipuncture: preparation of the child and/or companion, child positioning, distraction, breastfeeding, sweet-tasting solution with or without non-nutritive suction and topical anesthetic usage. The package of measures optimized the adoption of pain management strategies, highlighting its contribution to their professional growth. The patient care bundle optimized the adoption of strategies for pain management. The Convergent Care Research grounded in evidence-based practice showed appropriate, since it allowed the application of scientific findings in the care setting, considering its peculiarities.Descriptors: Pain Management, Child, Catheterization, Peripheral, Evidence-Based Nursing. Manejo del dolor de la venopunción pediátrica: un paquete de medidasResumen: Presentar el proceso de elaboración de un paquete de medidas para manejo del dolor de niños sometidos a la venopunción por el equipo de enfermería. Investigación Convergente Asistencial, del tipo antes y después de la intervención, realizada con el equipo de enfermería de una unidad pediátrica en el sur de Brasil. Paquete de medidas con seis estrategias seleccionadas por el equipo de enfermería que deben ser utilizadas antes y durante la venopunción: preparación del niño y/o acompañante, posicionamiento del niño, distracción, amamantamiento, solución dulce asociada o no a succión no nutritiva y anestésica tópica. Los participantes manifestaron satisfacción en cuanto al modo de elaboración del mismo, destacando la contribución de este para su crecimiento profesional. El paquete de medidas optimizó la adopción de estrategias para manejo del dolor. La Investigación Convergente Asistencial cimentada en la práctica basada en evidencias se mostró adecuada, visto que propició la aplicación de hallazgos científicos en el escenario asistencial considerando sus particularidades.Descriptores: Manejo del Dolor, Niño, Cateterismo Periférico, Enfermería Basada en la Evidencia.


2018 ◽  
Vol 25 (3) ◽  
pp. 213
Author(s):  
N.A. Nixon ◽  
H. Lim ◽  
C. Elser ◽  
Y.J. Ko ◽  
R. Lee-Ying ◽  
...  

Background Despite the high incidence and burden of cancer in Canadians, medical oncology (mo) rotations are not mandatory in most Canadian internal medicine (im) residency training programs.Methods All im residents scheduled for a mo rotation at 4 Canadian teaching cancer centres between 1 January 2013 and 31 December 2015 were invited to complete an online survey before and after their rotation. The survey was designed to evaluate perceptions of oncology, comfort in managing cancer patients, and basic oncology knowledge.Results The survey was completed by 68 im residents pre-rotation and by 48 (71%) post-rotation. Cancer-related learning was acquired mostly from mo physicians in clinic (35%). Self-directed learning, didactic teaching, and resident or fellow teaching accounted for 31%, 26%, and 10% respectively of learning acquisition. Comfort level in dealing with cancer patients and patients at end of life improved to 4.0/5 from 3.2/5 (p < 0.001) and to 4.0/5 from 3.6/5 (p = 0.003) respectively. Mean knowledge assessment score improved to 83% post-rotation from 76% pre-rotation (p = 0.003), with the greatest increase observed in general knowledge of common malignancies. The 3 topics ranked as most important to learn during a mo rotation were oncologic emergencies, common complications of treatment, and approach to diagnosis of cancer.Conclusions A rotation in mo improves the perceptions of im residents about oncology and their comfort level in dealing with cancer patients and patients at end of life. Overall cancer knowledge is also improved. Given those benefits, im residency programs should encourage most of their residents to complete a mo rotation.


1991 ◽  
Vol 9 (2) ◽  
pp. 335-338
Author(s):  
P P Carbone

Because cancer is the number one cause of mortality in Taiwan, a governmental decision was made to develop an experiment in medical oncology education using a United States-style training program in medical oncology in three Taipei, Taiwan, university hospitals. In the past, trainees from developing countries came to the United States or other foreign countries to receive specialty training. In doing so, the training did not necessarily prepare the individuals with skills to treat the indigenous cancers, nor did they work with other related specialists or support staff such as nursing and pharmacy, so important to providing good cancer care. This program involved 13 fellows with significant laboratory experience working with American faculty on-site. The major benefits of this model for oncology training are that the trainees developed important interdisciplinary relationships with local staff at each of the hospitals; they were involved in the treatment of the major cancer diseases of Taiwan such as nasopharyngeal, hepatocellular, and cervical cancers as well as breast, lung, and colon cancers; and they completed a certification process involving written and oral tests by two senior American oncologist examiners. Oncology services have been established at each of the hospitals and most of the fellows have expressed an interest or made arrangements to come to the United States to get additional research experience.


Blood ◽  
2012 ◽  
Vol 120 (21) ◽  
pp. 4270-4270
Author(s):  
Neil Love ◽  
Steven M. Horwitz ◽  
Sagar Lonial ◽  
Antonio Palumbo ◽  
Mitchell R Smith ◽  
...  

Abstract Abstract 4270 Background Clinical and translational research content in hematologic oncology is increasingly complex as new pathways and novel agents are investigated. Continuing oncology education (COE) for community-based oncologists (CBOs) must prioritize discussion of key new developments and clinical implications in order to optimize patient care. Clinical investigators (CIs) at tertiary academic institutions usually focus on specific areas in their research and practice, and these individuals play an important role in defining medical oncology standards of care and often participate in COE. Many CBOs and their patients turn to CIs for advice, answers and second opinions, and we hypothesized that CIs could provide a unique perspective in prioritizing COE content. This pilot project attempted to quantify and elucidate the experiences of investigators specializing in lymphoma/CLL (L) and multiple myeloma (MM), with the hope of gaining insight into current needs in COE that might directly impact patient care. Methods Between April 11 and May 16, 2012 we recruited 51 CIs (L: 26; MM: 25) to complete tandem questionnaires with about 60 items. Participants were provided a modest honorarium. As part of each survey and in order to document real-world experiences, CIs were asked to quantify how often they consult clinically with patients previously seen by another oncologist and how often they answer by phone or email case-related questions from CBOs. CIs also had the option to briefly describe up to 3 recent second opinion cases in which their recommendation differed significantly from that of a prior oncologist. Finally, CIs were also asked to define their usual nonprotocol treatment approaches to a variety of important clinical scenarios (L: 31; MM: 26) and then provide on a 4-point analog scale their perception of the need for additional COE in each of these specific areas. Results Participating CIs have considerable experience with CBOs and CBO-managed patients, providing clinical second opinions a mean of 4.0 times per week (L: 3.3; MM: 4.7; range 0–13) and responding to email or phone case queries a mean of 8.5 times per week (L: 8.4; MM: 8.6; range 0–40). CIs submitted a total of 89 case descriptions (L: 54; MM: 35) in which their treatment recommendation differed significantly from that of the prior oncologist. Specifically, in 19 of these cases (L: 13; MM: 6) the CI disagreed with the diagnosis, in 50 the choice of initial treatment differed (L: 28; MM: 22) and in 20 treatment for relapsed disease was questioned (L: 13; MM: 7). The top-rated areas of education need are presented in the table below. In many of these issues, recent research developments have resulted in controversy and heterogeneity in treatment approaches. Conclusions This pilot project demonstrates that CIs regularly evaluate patients previously managed by CBOs and also provide long-distance second opinions by email and phone that in some instances result in divergent recommendations. These informative experiences contribute to an overall perception of specific education needs that could be very useful in planning COE and in development of performance improvement programs. Additional research is needed to confirm and expand these findings and determine if this quantitative and targeted approach to COE enhances patient care and measurable clinical outcomes. Disclosures: Horwitz: Millennium: The Takeda Oncology Company: Research Funding; Seattle Genetics: Consultancy, Research Funding; Kyowa Hakko Kirin Co Ltd: Consultancy, Research Funding; Bristol-Myers Squibb Company: Consultancy; Celgene Corporation: Consultancy, Membership on an entity's Board of Directors or advisory committees, Research Funding; Allos Therapeutics: Consultancy, Membership on an entity's Board of Directors or advisory committees, Research Funding; Spectrum Pharmaceuticals: Consultancy, Research Funding. Lonial:Acetylon Pharmaceuticals Inc: Consultancy, Membership on an entity's Board of Directors or advisory committees; Bristol-Myers Squibb Company: Consultancy, Membership on an entity's Board of Directors or advisory committees; Celgene Corporation: Consultancy, Membership on an entity's Board of Directors or advisory committees; Merck and Company Inc: Consultancy, Membership on an entity's Board of Directors or advisory committees; Millennium: The Takeda Oncology Company: Consultancy, Membership on an entity's Board of Directors or advisory committees; Novartis Pharmaceuticals Corporation: Consultancy, Membership on an entity's Board of Directors or advisory committees; Onyx Pharmaceuticals Inc: Consultancy, Membership on an entity's Board of Directors or advisory committees. Palumbo:Bristol-Myers Squibb Company: Consultancy; Celgene Corporation: Consultancy, Speakers Bureau; Millinnium: The Takeda Oncology Company: Consultancy, Speakers Bureau; Amgen, Inc: Speakers Bureau. Smith:Allos Therapeutics: Speakers Bureau; Cephalon Inc: Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Millinnium: The Takeda Oncology Company: Speakers Bureau; Spectrum Pharmaceuticals Inc: Speakers Bureau; Genentech BioOncology: Speakers Bureau.


2020 ◽  
Vol 38 (29_suppl) ◽  
pp. 212-212
Author(s):  
Monaliben Patel ◽  
Debora S. Bruno ◽  
Lauren McCaulley ◽  
Piyush Srivastava

212 Background: Prior authorizations in medical oncology generate additional work and subsequent stress to providers, contributing to physician burnout. Denials of payments can also impact patient care and lead to loss of revenue for the institution. In 2018, first pass denial rates averaged 8.41% per month at our institution. Imaging/scans denials created the majority of this additional work for providers. We aimed to decrease the monthly first pass denial rate average of oncology scans by 25% by May 31, 2020. Methods: Following the creation of a process map of the current prior authorization process and a cause and effect diagram, we identified many factors that could not be controlled (i.e. Insurance company policies). We subsequently created a priority/pay-off-matrix using factors that we could control. Introducing standardized order template for oncology scans was identified as a high impact and feasible countermeasure. Plan-do-study-act cycles (PDSA) plan was developed using this countermeasure to achieve our aim. PDSA 1 included creating template for order entry, educating the nurse partners and advance practice providers (APPs). PDSA 2 included educating physicians and measuring the compliance rate of the template. PDSA 3 addressed the barriers for compliance and education on resources was provided. PDSA 4 included education of the prior authorization staff and reinforcement of template use. A sustainability plan created consisting of a designated RN liaison for review of peer-to-peer requests for oncology scans. Results: PDSA 1: 100% of the nurse partners and APPs were educated. PDSA2: 80% of physicians were educated and 32.8% compliance rate of template use. PDSA 3: 39.2% compliance. PDSA 4: 95% of the radiology prior authorization staff was educated. While our compliance rate for the standardized order template use did increase, we identified many other opportunities to improve the process. Unfortunately, due to COVID-19 pandemic outbreak, resources have been temporarily allocated to relief efforts and the sustainability plan continues to be a work in progress. Conclusions: Peer to peer requests for imaging/scans following authorization denials consume time and effort of providers contributing to burnout and potentially impacting patient care. While many factors cannot be controlled, standardizing ordering process and educating the involved personnel may decrease the number for peer to peer requests. ASCO’s quality training program process helped our institution identify a provider controlled barrier and helped standardize this approach.


Sign in / Sign up

Export Citation Format

Share Document